© 1995 American Heart Association, Inc.
Articles |
HDL-Mediated Efflux of Intracellular Cholesterol Is Impaired in Fibroblasts From Tangier Disease Patients
From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Federal Republic of Germany.
Correspondence to Prof Dr G. Schmitz, Institut für Klinische Chemie und Laboratoriumsmedizin, Universität Regensburg, D-93042 Regensburg, Germany.
Abstract To further elucidate the cellular mechanisms leading to HDL deficiency in Tangier disease, HDL-mediated cholesterol efflux was studied in cultured skin fibroblasts from Tangier patients. Both Tangier and control fibroblasts show specific saturable binding of HDL3 to the cell membrane (Bmax= 70 and 52 ng/mg protein, respectively; Kd=8.8 and 10.6 µg/mL, respectively). There was no appreciable uptake of HDL3 by Tangier and control fibroblasts, indicating that cholesterol efflux from fibroblasts occurs at the cell membrane. When cellular cholesterol was labeled to equilibrium by [14C]cholesterol incubation for 48 hours at 37°C, HDL3-mediated cholesterol efflux from Tangier fibroblasts was only 50% of control fibroblasts. To define this abnormality in HDL3-mediated cholesterol efflux more precisely, several additional experiments were performed. First, membrane desorption of cholesterol was determined after cell membranes were labeled with [14C]cholesterol for 3 hours at 15°C. With this labeling protocol, there was no difference in HDL3-mediated cholesterol efflux between control and Tangier fibroblasts. Second, efflux of newly synthesized sterols was determined after incorporation of the precursor [14C]mevalonolactone. Under these conditions, specific HDL3-mediated efflux of sterols was almost absent in Tangier fibroblasts. Third, cells were labeled by incubation with reconstituted [3H]cholesteryl-linoleate-LDL. Efflux of LDL-derived cholesterol was only slightly reduced for the first 4 hours of incubation. After 12 hours, there was no difference between control and Tangier cells. The combined data indicate that the reduced efflux of cholesterol from Tangier fibroblasts observed after homogeneous labeling is due to severely reduced efflux of newly synthesized sterol. Since it has been shown previously that efflux of newly synthesized cholesterol depends on HDL-mediated activation of protein kinase C (PKC), the effect of pharmacological activation of PKC was analyzed. Incubation of Tangier fibroblasts in the presence of 1,2-dioctanoylglycerol (10-5 mol/L), a membrane-permeable activator of PKC, led to normalization of HDL3-mediated efflux of newly synthesized cholesterol. These data were interpreted to indicate that impaired activation of PKC rather than a defect in the transport mechanism of cellular cholesterol leads to reduced HDL-mediated efflux of cholesterol from Tangier fibroblasts.
Key Words: cholesterol • Tangier disease • fibroblasts • HDL deficiency • lipid efflux
This article has been cited by other articles:
 |
|
 |
|
  P. G. Frank, M. W.-C. Cheung, S. Pavlides, G. Llaverias, D. S. Park, and M. P. Lisanti Caveolin-1 and regulation of cellular cholesterol homeostasis Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H677 - H686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Curtiss, D. T. Valenta, N. J. Hime, and K.-A. Rye What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport? Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 12 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yokoyama Assembly of High-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-i. Okuhira, M. L. Fitzgerald, D. A. Sarracino, J. J. Manning, S. A. Bell, J. L. Goss, and M. W. Freeman Purification of ATP-binding Cassette Transporter A1 and Associated Binding Proteins Reveals the Importance of {beta}1-Syntrophin in Cholesterol Efflux J. Biol. Chem., November 25, 2005; 280(47): 39653 - 39664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Kiss, J. Maric, and Y. L. Marcel Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux J. Lipid Res., September 1, 2005; 46(9): 1877 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ando, S. Tsuruoka, H. Yamamoto, T. Takamura, S. Kaneko, and A. Fujimura Effects of Pravastatin on the Expression of ATP-Binding Cassette Transporter A1 J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 420 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Walter, N. R. Forsyth, W. E. Wright, J. W. Shay, and M. G. Roth The Establishment of Telomerase-immortalized Tangier Disease Cell Lines Indicates the Existence of an Apolipoprotein A-I-inducible but ABCA1-independent Cholesterol Efflux Pathway J. Biol. Chem., May 14, 2004; 279(20): 20866 - 20873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Witting, J. N. Maiorano, and W. S. Davidson Ceramide Enhances Cholesterol Efflux to Apolipoprotein A-I by Increasing the Cell Surface Presence of ATP-binding Cassette Transporter A1 J. Biol. Chem., October 10, 2003; 278(41): 40121 - 40127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fukumoto, A. Deng, M. C. Irizarry, M. L. Fitzgerald, and G. W. Rebeck Induction of the Cholesterol Transporter ABCA1 in Central Nervous System Cells by Liver X Receptor Agonists Increases Secreted Abeta Levels J. Biol. Chem., December 6, 2002; 277(50): 48508 - 48513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Attie, Y. Hamon, A. R. Brooks-Wilson, M. P. Gray-Keller, M. L. E. MacDonald, V. Rigot, A. Tebon, L.-H. Zhang, J. D. Mulligan, R. R. Singaraja, et al. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken J. Lipid Res., October 1, 2002; 43(10): 1610 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kaplan, X. Gan, J. G. Menke, S. D. Wright, and T.-Q. Cai Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway J. Lipid Res., June 1, 2002; 43(6): 952 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Langmann, M. Porsch-Ozcurumez, S. Heimerl, M. Probst, C. Moehle, M. Taher, H. Borsukova, D. Kielar, W. E. Kaminski, E. Dittrich-Wengenroth, et al. Identification of Sterol-independent Regulatory Elements in the Human ATP-binding Cassette Transporter A1 Promoter. ROLE OF Sp1/3, E-BOX BINDING FACTORS, AND AN ONCOSTATIN M-RESPONSIVE ELEMENT J. Biol. Chem., April 19, 2002; 277(17): 14443 - 14450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Oram and R. M. Lawn ABCA1: the gatekeeper for eliminating excess tissue cholesterol J. Lipid Res., August 1, 2001; 42(8): 1173 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. von Eckardstein, J.-R. Nofer, and G. Assmann High Density Lipoproteins and Arteriosclerosis : Role of Cholesterol Efflux and Reverse Cholesterol Transport Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 13 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Christiansen-Weber, J. R. Voland, Y. Wu, K. Ngo, B. L. Roland, S. Nguyen, P. A. Peterson, and W.-P. Fung-Leung Functional Loss of ABCA1 in Mice Causes Severe Placental Malformation, Aberrant Lipid Distribution, and Kidney Glomerulonephritis As Well As High-Density Lipoprotein Cholesterol Deficiency Am. J. Pathol., September 1, 2000; 157(3): 1017 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santamarina-Fojo, K. Peterson, C. Knapper, Y. Qiu, L. Freeman, J.-F. Cheng, J. Osorio, A. Remaley, X.-P. Yang, C. Haudenschild, et al. Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter PNAS, July 5, 2000; 97(14): 7987 - 7992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Brousseau, G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size J. Lipid Res., July 1, 2000; 41(7): 1125 - 1135. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Brousseau, E. J. Schaefer, J. Dupuis, B. Eustace, P. Van Eerdewegh, A. L. Goldkamp, L. M. Thurston, M. G. FitzGerald, D. Yasek-McKenna, G. O'Neill, et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds J. Lipid Res., March 1, 2000; 41(3): 433 - 441. [Abstract] [Full Text]
|
|
|
|
|
|
J. Klucken, C. Buchler, E. Orso, W. E. Kaminski, M. Porsch-Ozcurumez, G. Liebisch, M. Kapinsky, W. Diederich, W. Drobnik, M. Dean, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport PNAS, January 18, 2000; 97(2): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Remaley, S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K. M. Peterson, C. Koch, I. Arnould, C. Prades, et al. Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred PNAS, October 26, 1999; 96(22): 12685 - 12690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Oram, A. J. Mendez, J. Lymp, T. J. Kavanagh, and C. L. Halbert Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells J. Lipid Res., October 1, 1999; 40(10): 1769 - 1781. [Abstract] [Full Text]
|
|
|
|
|
|
M. W. Freeman Effluxed lipids: Tangier Island's latest export PNAS, September 28, 1999; 96(20): 10950 - 10952. [Full Text] [PDF]
|
|
|
|
|
|
W. Drobnik, G. Liebisch, C. Biederer, B. Trumbach, G. Rogler, P. Muller, and G. Schmitz Growth and Cell Cycle Abnormalities of Fibroblasts From Tangier Disease Patients Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 28 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Batal, M. Tremblay, L. Krimbou, O. Mamer, J. Davignon, J. Genest Jr, and J. S. Cohn Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 655 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Eberhart, A. J. Mendez, and M. W. Freeman Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 836 - 846. [Abstract] [Full Text]
|
|
|
|
|
|
W. S. Garver, M. A. Deeg, R. F. Bowen, M. M. Culala, E. L. Bierman, and J. F. Oram Phosphoproteins Regulated by the Interaction of High-Density Lipoprotein With Human Skin Fibroblasts Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2698 - 2706. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Deeg, R. F. Bowen, J. F. Oram, and E. L. Bierman High Density Lipoproteins Stimulate Mitogen-Activated Protein Kinases in Human Skin Fibroblasts Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1667 - 1674. [Abstract] [Full Text]
|
|
|
|
|
|
A.T. Remaley, U.K. Schumacher, J.A. Stonik, B.D. Farsi, H. Nazih, and H.B. Brewer Decreased Reverse Cholesterol Transport from Tangier Disease Fibroblasts : Acceptor Specificity and Effect of Brefeldin on Lipid Efflux Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1813 - 1821. [Abstract] [Full Text]
|
|
|
|
|
|
W. Drobnik, C. Mollers, T. Resink, and G. Schmitz Activation of Phosphatidylinositol-Specific Phospholipase C in Response to HDL3 and LDL Is Markedly Reduced in Cultured Fibroblasts From Tangier Patients Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1369 - 1377. [Abstract] [Full Text]
|
|
|
|
|
|
N. Wang, D. L. Silver, P. Costet, and A. R. Tall Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1 J. Biol. Chem., October 13, 2000; 275(42): 33053 - 33058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Mendez, G. Lin, D. P. Wade, R. M. Lawn, and J. F. Oram Membrane Lipid Domains Distinct from Cholesterol/Sphingomyelin-Rich Rafts Are Involved in the ABCA1-mediated Lipid Secretory Pathway J. Biol. Chem., January 26, 2001; 276(5): 3158 - 3166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Porsch-Ozcurumez, T. Langmann, S. Heimerl, H. Borsukova, W. E. Kaminski, W. Drobnik, C. Honer, C. Schumacher, and G. Schmitz The Zinc Finger Protein 202 (ZNF202) Is a Transcriptional Repressor of ATP Binding Cassette Transporter A1 (ABCA1) and ABCG1 Gene Expression and a Modulator of Cellular Lipid Efflux J. Biol. Chem., April 6, 2001; 276(15): 12427 - 12433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Fitzgerald, A. J. Mendez, K. J. Moore, L. P. Andersson, H. A. Panjeton, and M. W. Freeman ATP-binding Cassette Transporter A1 Contains an NH2-terminal Signal Anchor Sequence That Translocates the Protein's First Hydrophilic Domain to the Exoplasmic Space J. Biol. Chem., April 27, 2001; 276(18): 15137 - 15145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Singaraja, V. Bocher, E. R. James, S. M. Clee, L.-H. Zhang, B. R. Leavitt, B. Tan, A. Brooks-Wilson, A. Kwok, N. Bissada, et al. Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1 J. Biol. Chem., August 31, 2001; 276(36): 33969 - 33979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gan, R. Kaplan, J. G. Menke, K. MacNaul, Y. Chen, C. P. Sparrow, G. Zhou, S. D. Wright, and T.-Q. Cai Dual Mechanisms of ABCA1 Regulation by Geranylgeranyl Pyrophosphate J. Biol. Chem., December 21, 2001; 276(52): 48702 - 48708. [Abstract] [Full Text] [PDF]
|
|